Form 4: Agenus Inc. Chairman Garo Armen Receives Stock in Lieu of Cash Salary

Garo H. Armen, Chairman and CEO of Agenus Inc., received 27,163 shares of common stock as salary in lieu of cash, according to a Form 4 filing.

Summary

• Garo H. Armen, Chairman and CEO of Agenus Inc., received 27,163 shares of Agenus Inc. common stock on March 22, 2024, as compensation in lieu of cash salary.
• The stock was issued at a price of $0.55 per share, which was the closing price of Agenus Inc. common stock on that date.
• These shares are fully vested upon issuance, in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan.
• Following the transaction, Dr. Armen directly owns 1,302,628 shares and indirectly owns 625,969 shares through IRA accounts and 579,000 shares as trustee and general partner.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of executive compensation. The acceptance of stock in lieu of cash could be seen as a slightly positive sign.

Positives

• The acceptance of stock in lieu of cash salary by the Chairman and CEO could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to executive compensation and beneficial ownership, common in the biopharmaceutical industry.

Stakeholder Impact

• The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.

Key Dates